These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2509075)

  • 21. Study of serum alanine-aminotransferase levels in blood donors in Spain.
    Lozano M; Cid J; Bedini JL; Mazzara R; Gimenez N; Mas E; Ballesta A; Ordinas A
    Haematologica; 1998 Mar; 83(3):237-9. PubMed ID: 9573678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.
    Acquaye JK; Tettey-Donkor D
    West Afr J Med; 2000; 19(4):239-41. PubMed ID: 11391831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surrogate testing for non-A, non-B hepatitis in Queensland, Australia: an ALT microtitre tray method for screening blood donors.
    Hyland CA; Douglas R; Mazzocchi R; Young IF
    Pathology; 1988 Jul; 20(3):271-4. PubMed ID: 3144700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing the blood supply for non-A, non-B hepatitis. A nonspecific approach for improving transfusion safety has a heterogeneous impact on blood donors.
    Menitove JE
    Am J Clin Pathol; 1990 Apr; 93(4):589-91. PubMed ID: 2108581
    [No Abstract]   [Full Text] [Related]  

  • 26. Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors.
    Tseng GC; Peng YC; Wang HH; Lee FH; Huang LR
    Hepatogastroenterology; 2008; 55(82-83):535-8. PubMed ID: 18613403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide ALT testing to prevent non-A, non-B hepatitis still on hold.
    Cowart VS
    JAMA; 1981 Dec; 246(24):2791-2. PubMed ID: 6796706
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors.
    Pourshams A; Malekzadeh R; Monavvari A; Akbari MR; Mohamadkhani A; Yarahmadi S; Seddighi N; Mohamadnejad M; Sotoudeh M; Madjlessi A
    J Gastroenterol Hepatol; 2005 Feb; 20(2):229-33. PubMed ID: 15683425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
    Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML
    Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alanine aminotransferase is a substitute marker of viral hepatitis].
    Zhiburt EB
    Vopr Virusol; 2005; 50(6):18-20. PubMed ID: 16408624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state.
    Brotman B; Prince AM
    Vox Sang; 1988; 54(3):144-7. PubMed ID: 2897145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum alanine aminotransferase (ALT) assay and incidence of posttransfusion non-A,non-B hepatitis.
    Barcena Marugan R; Zamora C; Moreno A; Erdozain Sosa JC; Perez Hernandez F; Lopez San Roman A
    Transfusion; 1989 Oct; 29(8):751. PubMed ID: 2508279
    [No Abstract]   [Full Text] [Related]  

  • 34. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.
    Silverstein MD; Mulley AG; Dienstag JL
    JAMA; 1984 Nov 23-30; 252(20):2839-45. PubMed ID: 6436522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum alanine aminotransferase and seronegative hepatitis.
    Meier P; Schmid M
    Ann Intern Med; 1988 May; 108(5):768. PubMed ID: 3128955
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical pictures of sporadic non-A, non-B acute hepatitis].
    Ichida F; Soga K
    Nihon Rinsho; 1981 Oct; 39(10):3226-34. PubMed ID: 6803020
    [No Abstract]   [Full Text] [Related]  

  • 37. Alanine aminotransferase screening and hepatitis C virus antibody.
    Burckhardt JJ; Friedli H; Gardi A; Heiniger HJ
    Lancet; 1990 Aug; 336(8712):447-8. PubMed ID: 1974981
    [No Abstract]   [Full Text] [Related]  

  • 38. Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden.
    Widell A; Sundström G; Hansson BG; Fex G; Moestrup T; Nordenfelt E
    Vox Sang; 1988; 54(3):154-9. PubMed ID: 3130727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor anti-HBc and ALT and non-A,non-B hepatitis.
    Ohto H; Ninomiya K
    Transfusion; 1989; 29(3):277-8. PubMed ID: 2493697
    [No Abstract]   [Full Text] [Related]  

  • 40. Alanine aminotransferase and posttransfusion hepatitis.
    Lacher DA
    JAMA; 1987 Feb; 257(8):1048. PubMed ID: 3100827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.